Victor Gheţie

8.4k total citations
141 papers, 6.8k citations indexed

About

Victor Gheţie is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Victor Gheţie has authored 141 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 78 papers in Radiology, Nuclear Medicine and Imaging and 77 papers in Immunology. Recurrent topics in Victor Gheţie's work include Monoclonal and Polyclonal Antibodies Research (76 papers), Toxin Mechanisms and Immunotoxins (51 papers) and Glycosylation and Glycoproteins Research (49 papers). Victor Gheţie is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (76 papers), Toxin Mechanisms and Immunotoxins (51 papers) and Glycosylation and Glycoproteins Research (49 papers). Victor Gheţie collaborates with scholars based in United States, Romania and Sweden. Victor Gheţie's co-authors include E. Sally Ward, Ellen S. Vitetta, Caius G. Radu, Raimund J. Ober, John Sjöquist, Jin‐Kyoo Kim, John Schindler, James G. Hubbard, Rodiça Lenkei and Felicia Antohe and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Victor Gheţie

141 papers receiving 6.4k citations

Peers

Countries citing papers authored by Victor Gheţie

Since Specialization

Citations

This map shows the geographic impact of Victor Gheţie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Gheţie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Gheţie more than expected).

Fields of papers citing papers by Victor Gheţie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Gheţie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Gheţie. The network helps show where Victor Gheţie may publish in the future.

Co-authorship network of co-authors of Victor Gheţie

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Gheţie. A scholar is included among the top collaborators of Victor Gheţie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Gheţie. Victor Gheţie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase I study of a combination of anti‐CD19 and anti‐CD22 immunotoxins (Combotox) in adult patients with refractory B‐lineage acute lymphoblastic leukaemia 2011 ·British Journal of Haematology ·John Schindler, (unknown), Farhad Ravandi, Yu‐Min Shen, Samir Parekh, (unknown), Stefan K. Barta, Victor Gheţie, Ellen S. Vitetta, Amit Verma	69
2	Partial Reduction of Human FOXP3+ CD4 T Cells In Vivo After CD25-directed Recombinant Immunotoxin Administration 2008 ·Journal of Immunotherapy ·Daniel J. Powell, Peter Attia, Victor Gheţie, John Schindler, Ellen S. Vitetta, Steven A. Rosenberg	51
3	Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics 2005 ·International Immunopharmacology ·Xiaoyun Liu, Laurentiu M. Pop, Derry C. Roopenian, Victor Gheţie, Ellen S. Vitetta, Joan E. Smallshaw	11
4	The anti-CD19 immunotoxin (HD37-dgRTA) is more effective when combined with chemotherapy 2005 ·Cancer Research ·(unknown), David Morgan, (unknown), Victor Gheţie, Ellen S. Vitetta, Larry Herrera	2
5	Interactions of Immunoglobulins Outside the Antigen-Combining Site 2004 ·Advances in immunology ·Roald Nezlin, Victor Gheţie	55
6	An Anti‐CD45RO Immunotoxin Kills Latently Infected Human Immunodeficiency Virus (HIV) CD4 T Cells in the Blood of HIV‐Positive Persons 2002 ·The Journal of Infectious Diseases ·Jesús Saavedra‐Lozano, Cynthia McCoig, Jinbo Xu, Yanying Cao, Philip Keiser, Victor Gheţie, Robert F. Siliciano, Janet D. Siliciano, Louis J. Picker, Octavio Ramilo, Ellen S. Vitetta	12
7	Transcytosis and Catabolism of Antibody 2002 ·Immunologic Research ·Victor Gheţie, E. Sally Ward	113
8	The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans 2001 ·International Immunology ·Mihail Firan, Roger E. Bawdon, Caius G. Radu, Raimund J. Ober, (unknown), Felicia Antohe, Victor Gheţie, E. Sally Ward	244
9	Chemical Construction of Immunotoxins 2001 ·Molecular Biotechnology ·Victor Gheţie, Ellen S. Vitetta	31
10	Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn 1999 ·European Journal of Immunology ·(unknown), Mihail Firan, Caius G. Radu, Cheol Hong Kim, Victor Gheţie, E. Sally Ward	178
11	Comparative studies of rat IgG to further delineate the Fc : FcRn interaction site 1998 ·European Journal of Immunology ·(unknown), Petru Cianga, Mark E. Mummert, Diana E. Stanescu, Victor Gheţie, E. Sally Ward	41
12	Clinical Trials with an Anti-CD25 Ricin A-Chain Experimental and Immunotoxin (RFT5-SMPT-dgA) in Hodgkin's Lymphoma 1998 ·Leukemia & lymphoma ·R. Schnell, E S Vitetta, John Schindler, Stefan Barth, U. Winkler, Peter Borchmann, ML Hansmann, Volker Diehl, Victor Gheţie, Andreas Engert	47
13	Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice 1996 ·European Journal of Immunology ·Victor Gheţie, James G. Hubbard, Jin‐Kyoo Kim, (unknown), (unknown), E. Sally Ward	380
14	The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn 1996 ·Molecular Immunology ·(unknown), James G. Hubbard, (unknown), Bertram T. Ober, Victor Gheţie, E. Sally Ward	96
15	Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site‐directed mutagenesis 1994 ·European Journal of Immunology ·Jin‐Kyoo Kim, (unknown), Victor Gheţie, E. Sally Ward	95
16	Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor 1994 ·European Journal of Immunology ·Jin‐Kyoo Kim, (unknown), Victor Gheţie, E. Sally Ward	117
17	Immunotoxins in the therapy of cancer: From bench to clinic 1994 ·Pharmacology & Therapeutics ·Victor Gheţie, Ellen S. Vitetta	35
18	Purification and properties of immunotoxins containing one vs. two deglycosylated ricin A chains 1993 ·Journal of Immunological Methods ·Victor Gheţie, Eric C. Swindell, Jonathan W. Uhr, Ellen S. Vitetta	20
19	A CD4-Derived Peptide Carrier Blocks Acute HIV-1 Infection In Vitro and Binds to gp120 in the Presence of Walter-Reed Stage 1-6 HIV ⁺ Sera 1992 ·AIDS Research and Human Retroviruses ·Victor Gheţie, T. S. Wheeler, (unknown), Jonathan W. Uhr, Ellen S. Vitetta	2
20	Large scale preparation of immunotoxins constructed with the Fab′ fragment of IgG1 murine monoclonal antibodies and chemically deglycosylated ricin A chain 1988 ·Journal of Immunological Methods ·Victor Gheţie, Maria-Ana Ghetie, J W Uhr, E S Vitetta	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact